GlassScriptPhysician profile
Cari Ann Betts
NPI 1578190500
$573.43
in general payments reported to CMS, 2019-2025
10 companies · $50.14 in 2025
The $50.14 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.51 · 2023: $261 · 2024: $205 · 2025: $50.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $184.57 | 2023-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Janssen Scientific Affairs, LLC | $118.47 | 2024 | Spravato |
| Alkermes, INC. | $67.65 | 2023 | Lybalvi, Aristada |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $51.76 | 2021-2024 | Caplyta |
| Lundbeck LLC | $46.33 | 2021-2023 | Rexulti |
| Corium, LLC | $27.39 | 2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $20.75 | 2024 | Qelbree |
| Idorsia Pharmaceuticals US INC | $19.78 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $19.18 | 2021 | |
| Ironshore Pharmaceuticals INC. | $17.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cari Betts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.